Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This descriptive, non-interventional study will collect information on the presence of risk factors in newly diagnosed ocular hypertension and open-angle glaucoma patients in Canada.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| There is no intervention in this study | This study is collecting information on the presence of risk factors in new diagnosed OH and OAG patients in Canada. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| There is no intervention in this study. | Other | This study is collecting information on the presence of risk factors in new diagnosed OH and OAG patients in Canada. |
|
| Measure | Description | Time Frame |
|---|---|---|
| To describe the presence and distribution of risk factors in subjects diagnosed with OH or OAG stratified according to geographic distribution in a Canadian population in the ophthalmologist practice. | duration of study |
| Measure | Description | Time Frame |
|---|---|---|
| To describe the severity of disease at the time of diagnosis and to determine if there is a correlation between risk factors, or number of risk factors, and the severity of disease at presentation. | duration of study |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Canadian population
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | Calgary | Alberta | T3E 7M8 | Canada | ||
| Pfizer Investigational Site |
Not provided
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
| Edmonton |
| Alberta |
| T5H 0X5 |
| Canada |
| Pfizer Investigational Site | Edmonton | Alberta | T5H 3V9 | Canada |
| Pfizer Investigational Site | Nanaimo | British Columbia | V9R 5B6 | Canada |
| Pfizer Investigational Site | Vancouver | British Columbia | V6K 1V7 | Canada |
| Pfizer Investigational Site | Williams Lake | British Columbia | V2G 1H1 | Canada |
| Pfizer Investigational Site | Winnipeg | Manitoba | R3C 0N2 | Canada |
| Pfizer Investigational Site | Sydney | Nova Scotia | B1P 1P2 | Canada |
| Pfizer Investigational Site | Brampton | Ontario | L6V 1B4 | Canada |
| Pfizer Investigational Site | Hamilton | Ontario | L8M 1L6 | Canada |
| Pfizer Investigational Site | London | Ontario | N6A 4V2 | Canada |
| Pfizer Investigational Site | Mississauga | Ontario | L5L 1W8 | Canada |
| Pfizer Investigational Site | Oakville | Ontario | L6H 3P1 | Canada |
| Pfizer Investigational Site | Oakville | Ontario | L6L 5G8 | Canada |
| Pfizer Investigational Site | Toronto | Ontario | M4N 3M5 | Canada |
| Pfizer Investigational Site | Toronto | Ontario | M5M 1B2 | Canada |
| Pfizer Investigational Site | Toronto | Ontario | M5T 2S8 | Canada |
| Pfizer Investigational Site | Montreal | Quebec | H1T 2M4 | Canada |
| Pfizer Investigational Site | Montreal | Quebec | H1V 1G5 | Canada |
| Pfizer Investigational Site | Sherbrooke | Quebec | J1K 1EB | Canada |
| Pfizer Investigational Site | Saskatoon | Saskatchewan | S7K 3H3 | Canada |
| ID | Term |
|---|---|
| D005902 | Glaucoma, Open-Angle |
| D009798 | Ocular Hypertension |
| D005901 | Glaucoma |
| ID | Term |
|---|---|
| D005128 | Eye Diseases |
Not provided
Not provided